System for predicting the recurrence of cancer in a cancer patient
AssigneeDefiniens AG
InventorsNathalie Harder, Maria Athelogou
Life of this patent
Estimating the term…
Loading patent…
AssigneeDefiniens AG
InventorsNathalie Harder, Maria Athelogou
Estimating the term…
A system predicts the recurrence of cancer. A first slice of a prostate tissue sample is stained so that luminal epithelial cells and basal epithelial cells are stained different colors. A first digital image is taken of the first slice. The second slice of the sample is stained so that M1 type macrophages and M2 type macrophages are differentially stained. A second digital image is taken of the second slice. The system analyzes the first digital image and defines regions of non-intact glands. Intact gland regions are then determined, and regions of stroma are identified. The system defines influence zones between non-intact regions and stroma regions. Using information from the second image, macrophages in the tissue corresponding to the influence zones are identified and counted. Based at least in part on this count, the system determines a score. The score is indicative of whether the patient will experience PSA recurrence.
A method comprising:
A method involving a Prostate-Specific Antigen (PSA) recurrence prediction system, the method comprising:
A method involving a Prostate-Specific Antigen (PSA) recurrence prediction system, the method comprising:
A method comprising:
Dependencies are inferred from the claim text.